VivoSeq
Other

Systemic Right Ventricle

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Systemic Right Ventricle is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

2

clinical trials

Unknown status1 · 50%
Completed1 · 50%

Clinical Trials

Trial Activity

Dapagliflozin in Systemic Right Ventricle (DAPA-SERVE)
Unknown status·—·Phase 4·NCT05717257·50 enrolled
Eplerenone in Systemic Right Ventricle
Completed·HHospital Universitari Vall d'Hebron Research Institute·Phase 4·NCT00703352·26 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)